Following treatment with sivelestat, IC-treated SLE NETs abolished their capacity to induce IFN-α response by pDCs (Figure 7, C and D), implying that NET-bound IL-33 signaling is abrogated due to lack of protease-mediated activation. Here, IL33 is linked to systemic lupus erythematosus.